202 related articles for article (PubMed ID: 31064747)
1. Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice.
Kasztan M; Fox BM; Lebensburger JD; Hyndman KA; Speed JS; Pollock JS; Pollock DM
Blood Adv; 2019 May; 3(9):1460-1475. PubMed ID: 31064747
[TBL] [Abstract][Full Text] [Related]
2. Impact of ET-1 and sex in glomerular hyperfiltration in humanized sickle cell mice.
Kasztan M; Pollock DM
Clin Sci (Lond); 2019 Jul; 133(13):1475-1486. PubMed ID: 31273050
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice.
Taylor CM; Kasztan M; Sedaka R; Molina PA; Dunaway LS; Pollock JS; Pollock DM
Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R630-R640. PubMed ID: 33624556
[TBL] [Abstract][Full Text] [Related]
4. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
5. Combined hydroxyurea and ET
Taylor C; Kasztan M; Tao B; Pollock JS; Pollock DM
Acta Physiol (Oxf); 2019 Feb; 225(2):e13178. PubMed ID: 30144292
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice.
Kasztan M; Fox BM; Speed JS; De Miguel C; Gohar EY; Townes TM; Kutlar A; Pollock JS; Pollock DM
J Am Soc Nephrol; 2017 Aug; 28(8):2443-2458. PubMed ID: 28348063
[TBL] [Abstract][Full Text] [Related]
7. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.
Nath KA; Grande JP; Croatt AJ; Frank E; Caplice NM; Hebbel RP; Katusic ZS
Am J Pathol; 2005 Apr; 166(4):963-72. PubMed ID: 15793278
[TBL] [Abstract][Full Text] [Related]
8. Urinary Transforming Growth Factor β-1 as a Marker of Renal Dysfunction in Sickle Cell Disease.
Ghobrial EE; Abdel-Aziz HA; Kaddah AM; Mubarak NA
Pediatr Neonatol; 2016 Jun; 57(3):174-80. PubMed ID: 26508723
[TBL] [Abstract][Full Text] [Related]
9. Enuresis and Hyperfiltration in Children With Sickle Cell Disease.
Zahr RS; Ding J; Kang G; Wang WC; Hankins JS; Ataga KI; Lebensburger JD; Porter JS
J Pediatr Hematol Oncol; 2022 Oct; 44(7):358-362. PubMed ID: 35180759
[TBL] [Abstract][Full Text] [Related]
10. Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models.
Saraf SL; Sysol JR; Susma A; Setty S; Zhang X; Gudehithlu KP; Arruda JAL; Singh AK; Machado RF; Gordeuk VR
Transl Res; 2018 Jul; 197():1-11. PubMed ID: 29476712
[TBL] [Abstract][Full Text] [Related]
11. The nephropathy of sickle cell trait and sickle cell disease.
Ataga KI; Saraf SL; Derebail VK
Nat Rev Nephrol; 2022 Jun; 18(6):361-377. PubMed ID: 35190716
[TBL] [Abstract][Full Text] [Related]
12. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease.
Bergmann S; Zheng D; Barredo J; Abboud MR; Jaffa AA
J Pediatr Hematol Oncol; 2006 Mar; 28(3):147-53. PubMed ID: 16679937
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy.
Saraf SL; Zhang X; Shah B; Kanias T; Gudehithlu KP; Kittles R; Machado RF; Arruda JA; Gladwin MT; Singh AK; Gordeuk VR
Haematologica; 2015 Oct; 100(10):1275-84. PubMed ID: 26206798
[TBL] [Abstract][Full Text] [Related]
14. An update on sickle cell nephropathy.
Alhwiesh A
Saudi J Kidney Dis Transpl; 2014 Mar; 25(2):249-65. PubMed ID: 24625990
[TBL] [Abstract][Full Text] [Related]
15. Nephrin as a biomarker of sickle cell glomerulopathy in Malawi.
Heimlich JB; Chipoka G; Elsherif L; David E; Ellis G; Kamthunzi P; Krysiak R; Mafunga P; Zhou Q; Cai J; Gopal S; Key NS; Ataga KI
Pediatr Blood Cancer; 2018 Jun; 65(6):e26993. PubMed ID: 29411937
[TBL] [Abstract][Full Text] [Related]
16. Assessment of renal function in Indian patients with sickle cell disease.
Lakkakula BVKS; Verma HK; Choubey M; Patra S; Khodiar PK; Patra PK
Saudi J Kidney Dis Transpl; 2017; 28(3):524-531. PubMed ID: 28540888
[TBL] [Abstract][Full Text] [Related]
17. Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.
Lebensburger JD; Aban I; Pernell B; Kasztan M; Feig DI; Hilliard LM; Askenazi DJ
Am J Hematol; 2019 Apr; 94(4):417-423. PubMed ID: 30592084
[TBL] [Abstract][Full Text] [Related]
18. Proteinuria in children with sickle cell disease.
Marsenic O; Couloures KG; Wiley JM
Nephrol Dial Transplant; 2008 Feb; 23(2):715-20. PubMed ID: 18065783
[TBL] [Abstract][Full Text] [Related]
19. Renal tubular dysfunction in children with sickle cell haemoglobinopathy.
Badr M; El Koumi MA; Ali YF; El-Morshedy S; Almonem NA; Hassan T; El Rahman RA; Afify M
Nephrology (Carlton); 2013 Apr; 18(4):299-303. PubMed ID: 23432792
[TBL] [Abstract][Full Text] [Related]
20. Renal protection by atorvastatin in a murine model of sickle cell nephropathy.
Zahr RS; Chappa P; Yin H; Brown LA; Ataga KI; Archer DR
Br J Haematol; 2018 Apr; 181(1):111-121. PubMed ID: 29527679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
